European Journal of Cancer; Sep 2017; vol. 82 ; p. 193-202
- Highlights
- Innovation in cancer care does not have to be complex or expensive.
- An innovation's value depends on patient outcomes, quality of life and system costs.
- A whole-system, whole-patient approach is required to guide investment in innovation.
- Patients must be more involved in defining and assessing the value of innovation.
- Investment in real-world data is essential to shape decisions about interventions.
